Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed withour AI-Immunology™ ...

A comprehensive eight-year study examining audiological outcomes of newborns screened for congenital cytomegalovirus (cCMV) ...

Targeting a specialized group of histones is safe and opens new therapeutic opportunities for treating blood cancers. This is the main finding of the latest research by Dr. Marcus Buschbeck and Dr.

Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple ...

At 21, Gerald Prandy’s battle with leukemia ended in cardiac arrest—but his consciousness traveled to a mysterious dimension ...

The AMPLIFY study [NCT03836261] did not include patients with del (17p), so that doublet is not relevant. The study that used ...

Lyndsey Sutherland, whose 15-year-old daughter died in 2021, is suing Mid Coast Medical Group under the Maine Wrongful Death ...

A novel tool could reduce the time it takes to diagnose and classify acute leukemias from days to hours through DNA ...

JJ Nevares beat cancer, now his family questions if emissions from a nearby medical sterilization plant were responsible.

In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of ...

Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...